ExecPay

Joshua Kazam

Overview2018

Overview

Joshua Kazam received $4M in total compensation at Allogene Therapeutics in 2018.

Source: SEC filing on April 24, 2019.
Kazam's 2018 pay

Related executives

We found five more executives who work or worked at Allogene Therapeutics.

David Chang

Allogene Therapeutics

Chief Executive Officer

4

Rafael Amado

Allogene Therapeutics

Chief Medical Officer

3

Alison Moore

Allogene Therapeutics

Chief Technical Officer

4

Eric Schmidt

Allogene Therapeutics

Chief Financial Officer

4

Veer Bhavnagri

Allogene Therapeutics

General Counsel

2

News

You may also like

Allogene Therapeutics